Washington, D.C. – House Republican Leader Kevin McCarthy (CA-23) praised the pro-growth agenda unveiled by Ways and Means Ranking Member Kevin Brady (TX-8) and the Republican members on the committee. The proposals are House GOP priorities for the next coronavirus relief package, which would complement the Senate legislation by focusing on long-term economic growth and medical security.
McCarthy released the following statement:
“Our top priority is the health of this nation. We remain committed to working with this administration to continue to find treatments and vaccines for COVID-19 that will keep Americans safe and help us fight the spread of this virus. At the same time we must continue to tackle the economic fallout this virus has caused to Americans’ livelihoods and the strength of our economy. And that is exactly what the Republican members on Ways and Means have set out to do in their pro-growth agenda. I commend Kevin Brady’s leadership for spearheading these important priorities that will be vital in rebuilding, renewing, and restoring the best economy of our lifetimes.
“This pandemic has also revealed that we have significant vulnerabilities in how essential products like medical supplies, pharmaceuticals, and electronic components, are sourced into the United States from foreign countries, specifically China. It is well past time we break China’s supply chain monopoly and we work toward reshoring production and manufacturing back to the United States. The policies outlined in this proposal will help accomplish that by incentivizing both bringing operations home from overseas and organic growth from existing domestic industries. These are the type of long-term policy decisions that will strengthen our future and help make us more self-sustainable.
“When Republicans were in the majority we worked together to pass historic tax reform that paved the way to the lowest unemployment rate this nation has seen in 50 years. It is these same pro-growth policies that are guaranteed to jumpstart the economy, strengthen our workforce, and ensure medical innovation and manufacturing thrive in the United States for the next century.”